METHOD FOR DETECTION TREATMENT AND PREVENTION OF NEUROLOGICAL DEVELOPMENT DISORDERS
A method for detection, treatment, and prevention of neurological development disorders utilizes an infrared imaging device, meridian theory of traditional Chinese medicine, and predetermined amounts of solid water particles to detect, treat, and prevent a neurological developmental disorder, such as autism. The method detects the disorder by initially identifying at least one hot spot on a patient with an infrared imaging device. At least one acupoint along a meridian pathway is identified. The hot spot is correlated with at least one acupoint located along the meridian pathway. The nexus of the hot spot and the meridian pathway indicates a potential neurological development disorder. A degree of irregularity of the internal organ is discerned by measuring a quantitative temperature at the nexus. A solid water particle is applied through a delivery means, such as oral, topical, vapor, and intravenous administration for treatment of the neurological developmental disorder.
1 . A method for detection, treatment, and prevention of a neurological development disorder, the method comprising:
determining at least one hot spot on a body with an infrared imaging device, the at least one hot spot being at least partially indicative of at least one internal organ of the body having an irregularity;
determining at least one acupoint along at least one meridian pathway, the at least one meridian pathway defined by a network that interconnects the at least one internal organ;
identifying a nexus between the at least one hot spot and the at least one acupoint;
discerning a degree of irregularity of the at least one internal organ by measuring a quantitative temperature at the nexus; and
administering a predetermined quantity of solid water particles with a delivery means, approximately to the nexus.
2 . The method of claim 1 , wherein the at least one meridian pathway includes at least one member selected from the group consisting of: a bladder meridian, a stomach meridian, a gallbladder meridian, a large intestine meridian, a small intestine meridian, and a tripe heater meridian.
3 . The method of claim 1 , wherein the at least one acupoint includes at least one member selected from the group consisting of: the left and right front center ears, the left and right inner point of the eyes, the left and right neck near the shoulder, the left and right forehead temple area, the left and right collar bone area, the left and right arm pits, and a line segment at the bottom of the neck.
4 . The method of claim 1 , wherein the infrared imaging device comprises a thermograph.
5 . The method of claim 1 , wherein the delivery means includes at least one member selected from the group consisting of: oral administration, topical administration, vapor administration, and intravenous administration.
6 . The method of claim 1 , wherein the oral administration comprises a liquid, a pill, or a gel consisting of the predetermined quantity of solid water particles.
7 . The method of claim 6 , wherein the topical administration comprises a cream consisting of the predetermined quantity of solid water particles.
8 . The method of claim 7 , wherein the vapor administration comprises a nebulizer and an inhaler consisting of the predetermined quantity of solid water particles.
9 . The method of claim 8 , wherein the intravenous administration comprises an intravenous injection consisting of the predetermined quantity of solid water particles.
10 . The method of claim 9 , wherein the cream is configured to be applied at least topically to at least one member selected from the group consisting of: the left and right front center ears, left and right inner points of the eyes, left and right forehead temple, left and right collar bone, and left and right arm pits.
11 . The method of claim 10 , wherein the step of administering a predetermined quantity of solid water particles approximately to the nexus with a delivery means, further includes administering the liquid, the pill, or the gel to a mother of a baby, who is breast fed by the mother.
12 . The method of claim 11 , wherein the step of administering a predetermined quantity of solid water particles approximately to the nexus with a delivery means, further includes administering the cream, the liquid, the pill, or the gel directly to the baby.
13 . The method of claim 1 , wherein the method further comprises at least one supplementary treatment, the at least one supplementary treatment including at least one member selected from the group consisting of: acupuncture, herbs, behavioral therapy, speech therapy, drugs, and at least one alternative method prescribed by a medical professional.
14 . The method of claim 1 , wherein the body comprises a body of a child.
15 . The method of claim 1 , wherein the neurological development disorder is an autistic spectrum disorder.
16 . A method for detection, treatment, and prevention of a neurological development disorder, the method comprising:
determining at least one hot spot on a body with a thermograph, at least one hot spot being at least partially indicative of at least one internal organ of the body having an irregularity;
determining at least one acupoint along at least one meridian pathway, the at least one meridian pathway defined by a network that interconnects the at least one internal organ;
identifying a nexus between the at least one hot spot and the at least one acupoint;
discerning a degree of irregularity of the at least one internal organ by measuring a quantitative temperature at the nexus;
administering a predetermined quantity of solid water particles with a delivery means in the form of a cream, a liquid, a pill, or a gel, approximately to the nexus; and
administering at least one supplementary treatment, the at least one supplementary treatment including at least one member selected from the group consisting of:
acupuncture, herbs, behavioral therapy, speech therapy, drugs, and at least one alternative method prescribed by a medical professional.
17 . The method of claim 16 , wherein the delivery means includes at least one member selected from the group consisting of: oral administration, topical administration, vapor administration, and intravenous administration.
18 . The method of claim 16 , wherein the cream is configured to be applied at least topically to at least one member selected from the group consisting of: the left and right front center ears, left and right inner points of the eyes, left and right forehead temple, left and right collar bone, abdominal and left and right arm pits.
19 . The method of claim 16 , wherein the vapor administration comprises a nebulizer and an inhaler consisting of the predetermined quantity of solid water particles.
20 . The method of claim 16 , wherein the intravenous administration comprises an intravenous injection consisting of the predetermined quantity of solid water particle.
21 . The method of claim 16 , wherein the delivery means includes at least one member selected from the group consisting of: oral administration, topical administration, vapor administration, and intravenous administration.
22 . The method of claim 21 , wherein the vapor administration comprises a nebulizer and an inhaler consisting of the predetermined quantity of solid water particles.
23 . The method of claim 21 , wherein the intravenous administration comprises an intravenous injection consisting of the predetermined quantity of solid water particles.
24 . A method for detection, treatment, and prevention of a neurological development disorder, the method comprising:
determining at least one acupoint along at least one meridian pathway, the at least one meridian pathway defined by a network that interconnects at least one internal organ; and
administering a predetermined quantity of solid water particles with a delivery means in the form of a cream, a liquid, a pill, or a gel, approximately to a nexus between the at least one meridian pathway and the at least one internal organ.
25 . The method of claim 24 , wherein the delivery means includes at least one member selected from the group consisting of: oral administration, topical administration, vapor administration, and intravenous administration.